What is Rumella Vaccine (M-M-R II)?
Rubella vaccine contains live attenuated Rubella virus, Wistar RA 27/3 live strain propagated on human diploid cells. Rubella vaccine is a vaccine used against rubella. The MMR vaccine is made by using live, attenuated (or weakened) strains of the measles, mumps, and rubella viruses. The first measles vaccines (an inactivated and a live virus product) became available in 1963, both of which were largely replaced by a further attenuated live virus vaccine that was licensed in 1968. The mumps vaccine first became available in 1967, followed by the rubella vaccine in 1969. These three vaccines were combined in 1971 to form the measles-mumps-rubella (MMR) vaccine.
This drug is commonly sold as Brand Name M-M-R II.
Indication/Contraindication for use of Rumella Vaccine (M-M-R II)
- Immunizations in persons from 12 month of age to puberty
- Pregnancy, febrile respiratory illness, severe disease of haemopoietic system, l.v injection
Side Effects of Rumella Vaccine (M-M-R II)
Burning or stinging, local pain, in duration at injection site.
Dosage and Prescribing Information for Rumella Vaccine (M-M-R II)
0.5 ml suboutaneously into upper arm.
Precautions while prescribing Rumella Vaccine (M-M-R II)
Acute hypersensitivity, don comitant immunization, blood transfusion.